ATE330226T1 - Pränatales screening für downs-syndrom - Google Patents

Pränatales screening für downs-syndrom

Info

Publication number
ATE330226T1
ATE330226T1 AT99918188T AT99918188T ATE330226T1 AT E330226 T1 ATE330226 T1 AT E330226T1 AT 99918188 T AT99918188 T AT 99918188T AT 99918188 T AT99918188 T AT 99918188T AT E330226 T1 ATE330226 T1 AT E330226T1
Authority
AT
Austria
Prior art keywords
marker
syndrome
screening
prenatal screening
downs syndrome
Prior art date
Application number
AT99918188T
Other languages
English (en)
Inventor
Nicholas John Wald
Original Assignee
Nicholas John Wald
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26313564&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE330226(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9809209.1A external-priority patent/GB9809209D0/en
Application filed by Nicholas John Wald filed Critical Nicholas John Wald
Application granted granted Critical
Publication of ATE330226T1 publication Critical patent/ATE330226T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/38Pediatrics
    • G01N2800/385Congenital anomalies
    • G01N2800/387Down syndrome; Trisomy 18; Trisomy 13
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/811Test for named disease, body condition or organ function
    • Y10S436/814Pregnancy
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/815Test for named compound or class of compounds
    • Y10S436/817Steroids or hormones
    • Y10S436/818Human chorionic gonadotropin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Stereo-Broadcasting Methods (AREA)
  • Detection And Prevention Of Errors In Transmission (AREA)
  • Monitoring And Testing Of Transmission In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
  • For Increasing The Reliability Of Semiconductor Memories (AREA)
  • Detection And Correction Of Errors (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Eye Examination Apparatus (AREA)
  • Investigating Strength Of Materials By Application Of Mechanical Stress (AREA)
AT99918188T 1998-04-29 1999-04-29 Pränatales screening für downs-syndrom ATE330226T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9809209.1A GB9809209D0 (en) 1998-04-29 1998-04-29 Antenatal screening for down's syndrome
GBGB9813905.8A GB9813905D0 (en) 1998-04-29 1998-06-26 Antenatal screening for down's syndrome

Publications (1)

Publication Number Publication Date
ATE330226T1 true ATE330226T1 (de) 2006-07-15

Family

ID=26313564

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99918188T ATE330226T1 (de) 1998-04-29 1999-04-29 Pränatales screening für downs-syndrom

Country Status (11)

Country Link
US (2) US6573103B1 (de)
EP (1) EP1076824B1 (de)
AT (1) ATE330226T1 (de)
AU (1) AU763171B2 (de)
CA (1) CA2330538C (de)
DE (1) DE69931910T2 (de)
DK (1) DK1076824T3 (de)
ES (1) ES2262319T3 (de)
IL (1) IL139302A (de)
PT (1) PT1076824E (de)
WO (1) WO1999056132A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003012445A1 (en) 2001-07-30 2003-02-13 Quest Diagnostics Investments Incorporated Methods and kits for detecting ita in a biological sample
US6627457B2 (en) 2001-07-30 2003-09-30 Quest Diagnostics Investments Incorporated Methods for detecting pregnancy
EP1578275A2 (de) * 2002-12-20 2005-09-28 Koninklijke Philips Electronics N.V. Verfahren zur feststellung von normal-messungen für einen patienten
GB0317476D0 (en) 2003-07-25 2003-08-27 Wright David E Methods and apparatus for screening for chromosomal abnormalities
US7244233B2 (en) * 2003-07-29 2007-07-17 Ntd Laboratories, Inc. System and method for utilizing shape analysis to assess fetal abnormality
US7315787B2 (en) * 2003-10-07 2008-01-01 Ntd Laboratories, Inc. Multi-marker screening protocol for fetal abnormalities
US10167508B2 (en) 2010-08-06 2019-01-01 Ariosa Diagnostics, Inc. Detection of genetic abnormalities
US10533223B2 (en) 2010-08-06 2020-01-14 Ariosa Diagnostics, Inc. Detection of target nucleic acids using hybridization
US11203786B2 (en) 2010-08-06 2021-12-21 Ariosa Diagnostics, Inc. Detection of target nucleic acids using hybridization
US11031095B2 (en) 2010-08-06 2021-06-08 Ariosa Diagnostics, Inc. Assay systems for determination of fetal copy number variation
US20140342940A1 (en) 2011-01-25 2014-11-20 Ariosa Diagnostics, Inc. Detection of Target Nucleic Acids using Hybridization
US8700338B2 (en) 2011-01-25 2014-04-15 Ariosa Diagnosis, Inc. Risk calculation for evaluation of fetal aneuploidy
US20130040375A1 (en) 2011-08-08 2013-02-14 Tandem Diagnotics, Inc. Assay systems for genetic analysis
US20130261003A1 (en) 2010-08-06 2013-10-03 Ariosa Diagnostics, In. Ligation-based detection of genetic variants
US20120034603A1 (en) 2010-08-06 2012-02-09 Tandem Diagnostics, Inc. Ligation-based detection of genetic variants
US9994897B2 (en) 2013-03-08 2018-06-12 Ariosa Diagnostics, Inc. Non-invasive fetal sex determination
US10131947B2 (en) 2011-01-25 2018-11-20 Ariosa Diagnostics, Inc. Noninvasive detection of fetal aneuploidy in egg donor pregnancies
US20120190021A1 (en) 2011-01-25 2012-07-26 Aria Diagnostics, Inc. Detection of genetic abnormalities
US11270781B2 (en) 2011-01-25 2022-03-08 Ariosa Diagnostics, Inc. Statistical analysis for non-invasive sex chromosome aneuploidy determination
US8756020B2 (en) 2011-01-25 2014-06-17 Ariosa Diagnostics, Inc. Enhanced risk probabilities using biomolecule estimations
US20130018700A1 (en) * 2011-07-14 2013-01-17 International Business Machines Corporation Optimizing product portfolios under customer choice
US8712697B2 (en) 2011-09-07 2014-04-29 Ariosa Diagnostics, Inc. Determination of copy number variations using binomial probability calculations
US10289800B2 (en) 2012-05-21 2019-05-14 Ariosa Diagnostics, Inc. Processes for calculating phased fetal genomic sequences
US10368782B2 (en) * 2012-06-09 2019-08-06 Ondine Tech Inc. Electro-medical system for neuro-muscular paralysis assessment
US9206417B2 (en) 2012-07-19 2015-12-08 Ariosa Diagnostics, Inc. Multiplexed sequential ligation-based detection of genetic variants
US20140222512A1 (en) * 2013-02-01 2014-08-07 Goodsnitch, Inc. Receiving, tracking and analyzing business intelligence data
US20140343982A1 (en) * 2013-05-14 2014-11-20 Landmark Graphics Corporation Methods and systems related to workflow mentoring
US10133996B2 (en) * 2014-04-22 2018-11-20 International Business Machines Corporation Object lifecycle analysis tool
EP2977912A1 (de) * 2014-07-25 2016-01-27 Franz-Peter Dr. Liebel Automatisierte Diagnostik
CN106796241B (zh) 2014-09-02 2019-07-12 沃拉克有限公司 确定先兆子痫风险的方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4874693A (en) 1986-10-10 1989-10-17 Mark Bogart Method for assessing placental dysfunction
US5506150A (en) 1987-07-09 1996-04-09 3I Research Exploitation Limited Prenatal screening for down's syndrome
US5258907A (en) 1989-01-17 1993-11-02 Macri James N Method and apparatus for detecting down syndrome by non-invasive maternal blood screening
US5316953A (en) 1989-01-17 1994-05-31 Macri James N Screening method for detecting fetal chromosal abnormalities
DK0666477T3 (da) 1989-01-17 2004-02-23 Jn Macri Technologies Llc Apparat til detektering af Downs syndrom ved hjælp af non-invasiv maternel blodscreening
GB9224965D0 (en) 1992-11-28 1993-01-20 Kodak Ltd Antenatal screening for chromosomal abnormalities
GB2291059B (en) 1993-03-19 1997-09-24 North Sydney Area Health Serv Papp-a,its immunodetection and uses
GB9306354D0 (en) 1993-03-26 1993-05-19 Kodak Ltd Antenatal screening for chromosomal abnormalities
GB9410345D0 (en) 1994-05-24 1994-07-13 Univ Oxford Brookes Method of genetic testing
US5716853A (en) * 1995-07-07 1998-02-10 Chiron Diagnostics Corporation Prenatal down syndrome screening with assays specific for UGP

Also Published As

Publication number Publication date
ES2262319T3 (es) 2006-11-16
DK1076824T3 (da) 2006-09-18
WO1999056132A1 (en) 1999-11-04
EP1076824B1 (de) 2006-06-14
DE69931910T2 (de) 2007-06-06
DE69931910D1 (en) 2006-07-27
US6573103B1 (en) 2003-06-03
IL139302A0 (en) 2001-11-25
AU763171B2 (en) 2003-07-17
CA2330538C (en) 2007-09-11
PT1076824E (pt) 2006-10-31
IL139302A (en) 2005-07-25
CA2330538A1 (en) 1999-11-04
EP1076824A1 (de) 2001-02-21
AU3621399A (en) 1999-11-16
US20030175981A1 (en) 2003-09-18

Similar Documents

Publication Publication Date Title
ATE330226T1 (de) Pränatales screening für downs-syndrom
DE1130397T1 (de) Ausrüstung zur Bestimmung eines Analyten in einer Probe
DE69824004D1 (de) Verfahren zur quantitativen bestimmung der genexpression mit hilfe der multiplexen competitiven reversen-transkriptase polymerase kettenreaktion
ATE241139T1 (de) Vorrichtung zur durchführung eines oder mehrerer kompetitiver immunoassays
ES2189799T3 (es) Metodo para detectar sindrome de down utilizando muestras de sangre seca.
ATE412896T1 (de) Pränatales down-syndrom-testverfahren unter benutzung von hyperglykosyliertem gonadotropin
WO2003001964A3 (en) Measurement testing of blood specimens
ATE98773T1 (de) Verfahren zur optischen analyse.
CA2022942A1 (en) Method of assessing sensitivity of hiv to zidovudine
DE3689490D1 (de) Elektronenstrahlprüfsonde zur Untersuchung integrierter Schaltungen.
DE69501326D1 (de) Differentielle expansion von fötalen stamzellen im mütterlichen kreislauf zur verwendung in der pränatalen genetischen analyse
ATE227024T1 (de) Verfahren und vorrichtung zur feststellung des down-syndroms durch nichtinvasive analyse von mütterlichem blut
DE69832161D1 (de) Pränatale diagnostische verfahren in vitro
ATE329265T1 (de) Verfahren zur instrumentellen bestimmung einer sich zeitabhängig ändernden messgrösse
DE69525400T2 (de) Vorgeburtliche Überprüfung von Schwangerschaftsabnormitäten
Berry et al. Analysis of maternal serum alpha‐fetoprotein and free beta human chorionic gonadotrophin in the first trimester: Implications for down's syndrome screening
DE60027267D1 (de) Verfahren zur bestimmung eines erhöhten risikos einer frau, ein foetus mit dem "down-syndrom" zu tragen
WO1999054707A3 (en) Fetal testing for prediction of low birth weight
WO2021150672A3 (en) Biomarkers for placenta accreta spectrum (pas) disorders
DE69721889D1 (de) Pränatales Testverfahren für Down-Syndrom
JP3427371B2 (ja) コンクリート構造物の強度判定方法
Bell et al. Reliable urine analysis in the management of hypertensive pregnancies
CA2604420A1 (en) Methods of determining an increased risk of a woman carrying a downs syndrome affected fetus by measuring an analyte in a biological sample
Herold et al. The Z-Problem. Test Methods for the Evaluation of Tensile Fracture in the Cross Section Direction
Crutzen et al. Sectioning PISC I and DDT Specimens

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1076824

Country of ref document: EP